European Urology Oncology Automated Bone Scan Index as an Imaging Biomarker to Predict Overall Survival in the Zometa European Study/SPCG11  Mariana Reza, Manfred Wirth, Teuvo Tammela, Virgilio Cicalese, Francisco Gomez Veiga, Peter Mulders, Kurt Miller, Andrea Tubaro, Frans Debruyne, Anup Patel, Christien Caris, Wim Witjes, Ola Thorsson, Per Wollmer, Lars Edenbrandt, Mattias Ohlsson, Elin Trägårdh, Anders Bjartell  European Urology Oncology  DOI: 10.1016/j.euo.2019.05.002 Copyright © 2019 Terms and Conditions

Fig. 1 Flowchart showing distribution of participants in the aBSI-ZEUS substudy from the main ZEUS study. aBSI=automated Bone Scan Index; hrPC=hormone-refractory prostate cancer; N=number of patients; ZA=zoledronic acid; ZEUS=Zometa European Study. European Urology Oncology DOI: (10.1016/j.euo.2019.05.002) Copyright © 2019 Terms and Conditions

Fig. 2 Kaplan-Meier curves showing patient survival of the entire aBSI study cohort stratified by aBSI change from baseline to 4-yr follow-up. aBSI=automated Bone Scan Index; BSI=Bone Scan Index; Cum=cumulative. European Urology Oncology DOI: (10.1016/j.euo.2019.05.002) Copyright © 2019 Terms and Conditions